Fluidigm: Rises after hedge fun Caligan takes 11% stake

Standard BioTools

11/05/2021 19:07

** Biotech co's shares  FLDM.O  jump 14.7% to $5.36 
    ** Activist investor Caligan Partners takes an 11.2% stake
in FLDM, a COVID-19 test maker [https://bit.ly/2Rapboc
]
    ** Caligan says FLDM is undervalued and represent an
attractive investment opportunity
    ** Says it intends to discuss a potential strategic review
of FLDM or sale of some of its businesses with co
    ** Caligan is a New York hedge fund co-founded by David
Johnson, a former executive at the Carlyle Group  urn:newsml:reuters.com:*:nL1N2MX2D4
    ** FLDM has a market cap of $350.1 mln - Refinitiv data
    ** FLDM had fallen 22.2% YTD as of its last close

 (Reporting by Amruta Khandekar)
 ((Amruta.Khandekar@thomsonreuters.com;))